Literature DB >> 2575030

Chronic granulomatous disease of childhood: gastric manifestation and response to salazosulfapyridine therapy.

J Stopyrowa1, K Fyderek, B Sikorska, D Kowalczyk, M Zembala.   

Abstract

The case history of a 10-year-old boy with chronic granulomatous disease (CGD) and gastric obstruction is presented. First abdominal symptoms occurred at 4 years of age when antral narrowing was detected. Due to unresponsiveness to antibiotic and steroid treatment, salazosulfapyridine therapy was initiated. Objective remission was observed within 3 months and salazosulfapyridine was withdrawn after a further 6 months of therapy. At 6 years of age clinical and radiological recurrence of gastric obstruction was observed. Salazosulfapyridine was reinstated and continued as maintenance therapy. The child has been well for more than 4 years. Salazosulfapyridine therapy can be recommended as safe conservative treatment of gastric obstruction in CGD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575030     DOI: 10.1007/bf02024330

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

Review 1.  Chronic granulomatous disease.

Authors:  R B Johnston; S L Newman
Journal:  Pediatr Clin North Am       Date:  1977-05       Impact factor: 3.278

2.  Gastric antral narrowing in chronic granulomatous disease of childhood.

Authors:  N T Griscom; J A Kirkpatrick; B R Girdany; W E Berdon; R J Grand; G G Mackie
Journal:  Pediatrics       Date:  1974-10       Impact factor: 7.124

3.  Gastrointestinal manifestations of chronic granulomatous disease.

Authors:  M E Ament; H D Ochs
Journal:  N Engl J Med       Date:  1973-02-22       Impact factor: 91.245

4.  Chronic granulomatous disease of childhood. Probable diffuse gastric involvement.

Authors:  M A Hartenberg; M B Kodroff
Journal:  Pediatr Radiol       Date:  1984

5.  Progressive antral narrowing in an adolescent.

Authors:  R M Gore; R B Port
Journal:  JAMA       Date:  1982-01-01       Impact factor: 56.272

6.  Chemiluminescence response in normal human phagocytes. I. Automated measurements using a standard liquid scintillation counter.

Authors:  J P Robinson; R Penny
Journal:  J Clin Lab Immunol       Date:  1982-04

7.  Upper gastrointestinal and ultrasound examinations of gastric antral involvement in chronic granulomatous disease.

Authors:  P A Kopen; W H McAlister
Journal:  Pediatr Radiol       Date:  1984

8.  Gastrointestinal complications of chronic granulomatous disease: surgical implications.

Authors:  M W Mulholland; J P Delaney; R L Simmons
Journal:  Surgery       Date:  1983-10       Impact factor: 3.982

9.  Chronic granulomatous disease of childhood: a changing pattern?

Authors:  H H Frayha; W D Biggar
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

10.  Gastric outlet obstruction in chronic granulomatous disease of childhood.

Authors:  J D Dickerman; R B Colletti; J P Tampas
Journal:  Am J Dis Child       Date:  1986-06
View more
  1 in total

Review 1.  Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase.

Authors:  Michela G Schäppi; Vincent Jaquet; Dominique C Belli; Karl-Heinz Krause
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.